Overview

Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will compare the performance of three combination metered dose inhalation devices and the variability of mometasone and formoterol doses delivered to the lungs in a healthy volunteer population
Phase:
Phase 1
Details
Lead Sponsor:
Novartis
Collaborator:
Schering-Plough
Treatments:
Formoterol Fumarate
Mometasone Furoate